Conference Details - Agenda
View all Conferences
This activity is approved for AMA PRA Category 1 Credit™
Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA Category 1 CME credit for the PRA from organizations accredited by the ACCME.
Continuing Education Information
Physicians: Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.This activity is approved for AMA PRA Category 1 Credit™
Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA Category 1 CME credit for the PRA from organizations accredited by the ACCME.
Molecular Oncology: The Sixth Vital Sign, What Every Oncologist Should Know
Arizona Grand Resort
Phoenix, AZ
January 22-24, 2009
Thursday, Jan 22, 2009
| 3:30 pm | Registration and Refreshments |
| 4:00 pm | Welcome and Introductions Ramesh K. Ramanathan |
| Therapeutics Based on Genotype and Phenotype Moderator: Ramesh K. Ramanathan |
|
| 4:10 pm | Presession Survey |
| 4:20 pm | Case Presentation: BRCA1 Mutation–Associated Ovarian Cancer Stephen P. Anthony |
| 4:50 pm | Markers of Responsiveness to HER2-Targeted Therapies Francisco Esteva |
| 5:20 pm | Translational Approaches in Lung Cancer: Lessons Learned From Targeting Epidermal Growth Factor Receptor Alex Adjei |
| 5:50 pm | Comparing and Contrasting New Antiangiogenic TKIs Raoul Tibes |
| 6:10 pm | Postsession Survey and Question-and-Answer Session |
| 6:30 pm | Adjourn |
| 6:45 pm | Reception |
Educational Grants
An educational grant for this activity was provided by:
- Genentech BioOncology
- Merck Oncology
- Celgene Corporation
- Nektar Therapeutics
- Proacta
- Threshold Pharmaceuticals, Inc.
- ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company